Author:
Daimon Takashi,Hirakawa Akihiro,Matsui Shigeyuki
Reference42 articles.
1. Berry, S.M., Carlin, B.P., Lee, J.J., Müller, P.: Chapter 3. Phase I studies. In: Berry, S.M., Carlin, B.P., Lee, J.J., Müller, P. (eds.) Bayesian Adaptive Methods for Clinical Trials, First Edition, pp. 87–135. Chapman and Hall/CRC Press, Boca Raton, FL (2010)
2. Braun, T.M., Alonzo, T.A.: Beyond the 3+3 method: expanded algorithms for dose-escalation in phase I oncology trials of two agents. Clin. Trials 8(3), 247–259 (2011)
3. Chang, M.: Adaptive Design Theory and Implementation Using SAS and R, 1st edn. Chapman and Hall/CRC Press, Boca Raton, FL (2008a)
4. Chang, M.: Classical and Adaptive Clinical Trial Designs Using ExpDesign Studio, 1st edn. John Wiley & Sons, Hoboken, NJ (2008b)
5. Cheung, Y.K.: Coherence principles in dose-finding studies. Biometrika 92(4), 863–873 (2005)